Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment.(Damman K, Perez AC, Anand IS, Komajda M, McKelvie RS, Zile MR, Massie B, Carson PE, McMurray JJ.) Renal P2 Receptors and Hypertension. (Menzies RI, Unwin RJ, Bailey MA.) The aging kidney revisited: a systematic review. (Bolignano D, Mattace-Raso F, Sijbrands EJ, Zoccali C.) Does a vitamin D boost help in resistant hypertension control? (Zoccali C, Mallamaci F.) A look at the upper heart chamber: the left atrium in chronic kidney disease.(Paoletti E, Zoccali C.) Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario?(Liabeuf S, Okazaki H, Desjardins L, Fliser D, Goldsmith D, Covic A, Wiecek A, Ortiz A, Martinez-Castelao A, Lindholm B, Suleymanlar G, Mallamaci F, Zoccali C, London G, Massy ZA.) Statins for the prevention of contrast-induced acute kidney injury.(Ball T, McCullough PA.) Meta-analysis on efficacy of statins for prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography.(Ukaigwe A, Karmacharya P, Mahmood M, Pathak R, Aryal MR, Jalota L, Donato AA.) Acute kidney injury: Short-term statin therapy for prevention of contrast-induced AKI.(Mikhailidis DP, Athyros VG.) Focus on lipids: high-density lipoprotein cholesterol and its associated lipoproteins in cardiac and renal disease.(Shin HJ, McCullough PA.) Risk Factors for Heart Failure in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl.(Chin MP, Wrolstad D, Bakris GL, Chertow GM, de Zeeuw D, Goldsberry A, Linde PG, McCullough PA, McMurray JJ, Wittes J, Meyer CJ.) Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction.(Gori M, Senni M, Gupta DK, Charytan DM, Kraigher-Krainer E, Pieske B, Claggett B, Shah AM, Santos AB, Zile MR, Voors AA, McMurray JJ, Packer M, Bransford T, Lefkowitz M, Solomon SD; for the PARAMOUNT Investigators.) Ultrafiltration for the treatment of congestion: a window into the lung for a better caress to the heart.(Rossi GP, Calò LA, Maiolino G, Zoccali C.) Association of renal resistive index with aortic pulse wave velocity in hypertensive patients.(Geraci G, Mulè G, Geraci C, Mogavero M, D'Ignoto F, Morreale M, Foraci AC, Cottone S.) Mediation Analysis of Aortic Stiffness and Renal Microvascular Function.(Woodard T, Sigurdsson S, Gotal JD, Torjesen AA, Inker LA, Aspelund T, Eiriksdottir G, Gudnason V, Harris TB, Launer LJ, Levey AS, Mitchell GF.)

Come Associarsi

Per associarsi basta scaricare e presentare la [ domanda di ammissione ] compilata in tutte le sue parti inviandola come allegato al form sottostante.

Una volta che la domanda di ammissione sarà approvata dal Consiglio Direttivo della Società, verrà comunicato ufficialmente dalla Segreteria e sarà possibile effettuare il pagamento della quota associativa, per poter completare l’iscrizione.

Il costo della quota associativa è di euro 50,00.
Per il Medici già iscritti alle Società Scientifiche: AMD, ANMCO, ANCE, ARCA, FADOI, FIC, FIMMG, FIR, SIC, SID, SIIA, SIMG, SIMI, SIN, SIPREC, il costo della quota associativa è di euro 30,00.

Ai giovani medici under 35 verrà applicato uno sconto pari al 50% della quota intera.

Giovani specializzandi in: Nefrologia, Medicina Interna, Endocrinologia, Cardiologia,durante il corso di specializzazione la quota di iscrizione è gratuita.

E’ possibile effettuare il pagamento della quota associativa tramite bonifico bancario:

Credito Siciliano

IBAN: IT 12 C 05216 04609 000009022601